Intravitreal Anti-VEGF Therapy for Choroidal Neovascularization-Associated with Best Vitelliform Macular Dystrophy

被引：0
|
作者：
Grigorian, Florin [1 ]
Vasconcelos, Huber Martins [1 ]
Bailey, Steven T. [1 ]
Lujan, Brandon J. [1 ]
Campbell, J. Peter [1 ]
Lin, Phoebe [1 ]
Weleber, Richard G. [1 ]
Pennesi, Mark E. [1 ]
Yang, Paul [1 ]
机构：
[1] OHSU Casey Eye Inst, Portland, OR USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3145
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Long-Term Efficacy of Intravitreal Anti-VEGF Therapy for Choroidal Neovascularization in a Case of Fundus Flavimaculatus (FFM)
    Zygoula, Ioanna
    Hefner, Lars
    Gerding, Heinrich
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2022, 239 (04) : 531 - 533
  • [42] Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to laser photocoagulation
    Han, D. P.
    McAllister, J. T.
    Weinberg, D. V.
    Kim, J. E.
    Wirostko, W. J.
    EYE, 2010, 24 (04) : 713 - 716
  • [43] Safety review of anti-VEGF therapy in patients with myopic choroidal neovascularization
    Ng, Danny S. C.
    Ho, Mary
    Iu, Lawrence P. L.
    Lai, Timothy Y. Y.
    EXPERT OPINION ON DRUG SAFETY, 2022, 21 (01) : 43 - 54
  • [44] Combined intravitreal anti-VEGF and verteporfin photodynamic therapy for juxtafoveal and extrafoveal choroidal neovascularization as an alternative to laser photocoagulation
    D P Han
    J T McAllister
    D V Weinberg
    J E Kim
    W J Wirostko
    Eye, 2010, 24 : 713 - 716
  • [45] Choroidal new vessels in type 1 myotonic dystrophy-related macular dystrophy respond to anti-VEGF therapy
    M S Zinkernagel
    S J Hornby
    R E MacLaren
    Eye, 2012, 26 : 1595 - 1596
  • [46] Choroidal new vessels in type 1 myotonic dystrophy-related macular dystrophy respond to anti-VEGF therapy
    Zinkernagel, M. S.
    Hornby, S. J.
    MacLaren, R. E.
    EYE, 2012, 26 (12) : 1595 - 1596
  • [47] Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Choroidal Neovascularization Due to Sorsby Macular Dystrophy
    Kapoor, Kapil G.
    Bakri, Sophie J.
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (04) : 444 - 447
  • [48] Intravitreal Anti-VEGF Therapy is not associated with cardiovascular Events
    Bitzer, Michaela
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2019, 236 (09) : 1060 - +
  • [49] Anti-VEGF treatment for choroidal neovascularization complicating pattern dystrophy-like deposit associated with pseudoxanthoma elasticum
    Parodi, Maurizio Battaglia
    Romano, Francesco
    Marchese, Alessandro
    Arrigo, Alessandro
    Llorenc, Victor
    Cicinelli, Maria Vittoria
    Bandello, Francesco
    Adan, Alfredo
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (02) : 273 - 278
  • [50] Choroidal thickness in exudative agerelated macular degeneration and influence of intravitreal anti-VEGF treatment
    Rodrigues, Rita
    Moleiro, Ana
    Carneiro, Angela
    Falcao, Manuel
    ACTA OPHTHALMOLOGICA, 2022, 100
12345